Culture

Our gut-brain connection

image: MIT researchers have developed an "organs-on-a-chip" system that replicates interactions between the brain, liver, and colon.

Image: 
Martin Trapecar, MIT

CAMBRIDGE, MA -- In many ways, our brain and our digestive tract are deeply connected. Feeling nervous may lead to physical pain in the stomach, while hunger signals from the gut make us feel irritable. Recent studies have even suggested that the bacteria living in our gut can influence some neurological diseases.

Modeling these complex interactions in animals such as mice is difficult to do, because their physiology is very different from humans'. To help researchers better understa nd the gut-brain axis, MIT researchers have developed an "organs-on-a-chip" system that replicates interactions between the brain, liver, and colon.

Using that system, the researchers were able to model the influence that microbes living in the gut have on both healthy brain tissue and tissue samples derived from patients with Parkinson's disease. They found that short-chain fatty acids, which are produced by microbes in the gut and are transported to the brain, can have very different effects on healthy and diseased brain cells.

"While short-chain fatty acids are largely beneficial to human health, we observed that under certain conditions they can further exacerbate certain brain pathologies, such as protein misfolding and neuronal death, related to Parkinson's disease," says Martin Trapecar, an MIT postdoc and the lead author of the study.

Linda Griffith, the School of Engineering Professor of Teaching Innovation and a professor of biological engineering and mechanical engineering, and Rudolf Jaenisch, an MIT professor of biology and a member of MIT's Whitehead Institute for Medical Research, are the senior authors of the paper, which appears today in Science Advances.

The gut-brain connection

For several years, Griffith's lab has been developing microphysiological systems -- small devices that can be used to grow engineered tissue models of different organs, connected by microfluidic channels. In some cases, these models can offer more accurate information on human disease than animal models can, Griffith says.

In a paper published last year, Griffith and Trapecar used a microphysiological system to model interactions between the liver and the colon. In that study, they found that short-chain fatty acids (SCFAs), molecules produced by microbes in the gut, can worsen autoimmune inflammation associated with ulcerative colitis under certain conditions. SCFAs, which include butyrate, propionate, and acetate, can also have beneficial effects on tissues, including increased immune tolerance, and they account for about 10 percent of the energy that we get from food.

In the new study, the MIT team decided to add the brain and circulating immune cells to their multiorgan system. The brain has many interactions with the digestive tract, which can occur via the enteric nervous system or through the circulation of immune cells, nutrients, and hormones between organs.

Several years ago, Sarkis Mazmanian, a professor of microbiology at Caltech, discovered a connection between SCFAs and Parkinson's disease in mice. He showed that SCFAs, which are produced by bacteria as they consume undigested fiber in the gut, sped up the progression of the disease, while mice raised in a germ-free environment were slower to develop the disease.

Griffith and Trapecar decided to further explore Mazmanian's findings, using their microphysiological model. To do that, they teamed up with Jaenisch's lab at the Whitehead Institute. Jaenisch had previously developed a way to transform fibroblast cells from Parkinson's patients into pluripotent stem cells, which can then be induced to differentiate into different types of brain cells -- neurons, astrocytes, and microglia.

More than 80 percent of Parkinson's cases cannot be linked to a specific gene mutation, but the rest do have a genetic cause. The cells that the MIT researchers used for their Parkinson's model carry a mutation that causes accumulation of a protein called alpha synuclein, which damages neurons and causes inflammation in brain cells. Jaenisch's lab has also generated brain cells that have this mutation corrected but are otherwise genetically identical and from the same patient as the diseased cells.

Griffith and Trapecar first studied these two sets of brain cells in microphysiological systems that were not connected to any other tissues, and found that the Parkinson's cells showed more inflammation than the healthy, corrected cells. The Parkinson's cells also had impairments in their ability to metabolize lipids and cholesterol.

Opposite effects

The researchers then connected the brain cells to tissue models of the colon and liver, using channels that allow immune cells and nutrients, including SCFAs, to flow between them. They found that for healthy brain cells, being exposed to SCFAs is beneficial, and helps them to mature. However, when brain cells derived from Parkinson's patients were exposed to SCFAs, the beneficial effects disappeared. Instead, the cells experienced higher levels of protein misfolding and cell death.

These effects were seen even when immune cells were removed from the system, leading the researchers to hypothesize that the effects are mediated by changes to lipid metabolism.

"It seems that short-chain fatty acids can be linked to neurodegenerative diseases by affecting lipid metabolism rather than directly affecting a certain immune cell population," Trapecar says. "Now the goal for us is to try to understand this."

The researchers also plan to model other types of neurological diseases that may be influenced by the gut microbiome. The findings offer support for the idea that human tissue models could yield information that animal models cannot, Griffith says. She is now working on a new version of the model that will include micro blood vessels connecting different tissue types, allowing researchers to study how blood flow between tissues influences them.

"We should be really pushing development of these, because it is important to start bringing more human features into our models," Griffith says. "We have been able to start getting insights into the human condition that are hard to get from mice."

Credit: 
Massachusetts Institute of Technology

Association between unemployment insurance, food insecurity among people who lost jobs during COVID-19 pandemic in US

What The Study Did: This study investigated how unemployment insurance and a $600 per week federal supplement to unemployment insurance were associated with food insecurity among people in low- and middle-income households who lost jobs during the COVID-19 pandemic.

Authors: Julia Raifman, Sc.D., of the Boston University School of Public Health, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.35884)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Racial, ethnic differences in diagnostic imaging at children's hospitals emergency departments

What The Study Did: Researchers examined if the use of diagnostic imaging for children receiving care in pediatric emergency departments in the United States differs by race and ethnicity.

Authors: Jennifer R. Marin, M.D., M.Sc., of the University of Pittsburgh School of Medicine, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.33710)

Editor's Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Genes that dance to the circadian rhythm

In 2017, the Nobel Prize in Physiology or Medicine went to three scientists who uncovered the molecular mechanisms that control the circadian rhythm, otherwise known as the "wake-sleep" cycle. To carry out their work, the scientists used the common fruit fly Drosophila melanogaster, making this the sixth Nobel to be awarded to research involving it.

Fruitful fruit flies

Life scientists have been using Drosophila for over a century now. First proposed by entomologist Charles W. Woodworth as a model organism, its use in research was pioneered by geneticist Thomas H. Morgan who ran his famous Fly Room at Columbia University in the early 1900's.

Sharing around 60% of human DNA, the humble insect has been the linchpin of countless scientific discoveries, from genetic inheritance and gene mutation to neurodegenerative disorders like Alzheimer's and Parkinson's.

Circadian rhythms

Drosophila has also been used extensively in the study of the circadian rhythm, a process shared by virtually all living organisms, including animals, plants, and even microbes. Apart from sleeping and waking, it affects multiple aspects of our bodies, including hormone release, eating and digestion, as well as body temperature.

In fact, the study of circadian rhythms has grown into its own field: chronobiology. And given that a person's circadian rhythm seems to dictate when certain drugs must be taken in order to maximize their effects, a new branch of medicine has also emerged recently: chronopharmacology.

Gene rhythms

Now, scientists led by Maria Litovchenko and Bart Deplancke at EPFL's School of Life Sciences have carried out an extensive study using Drosophila to study how different genes in various tissues of the animal are regulated so that they "know" when to turn on and off during the course of a day, i.e. in function of the circadian clock. "We wanted to assess how these molecular rhythms vary in a natural fruit fly population and how they are affected by genomic variation," adds Deplancke. The study is published in Science Advances.

The scientists turned to a fly resource called the Drosophila Genetic Reference Panel (DGRP), which contains more than 200 genetically distinct lines of the insect. Each line's genome has been fully sequenced so that scientists can spot differences between genotypes and then connect them to differences between phenotypes, thereby linking genes to their functions.

From the DGRP, the scientists sampled more than 700 tissue-specific "transcriptomes". In an organism or a tissue or just a cell, genes are decoded or "transcribed" into mRNA, which is then used to put together a protein. So a transcriptome is essentially a set of all RNA transcripts from an organism's DNA, coding or non-coding.

In this study, the scientists used the mRNA from a reference, "control", fly strain and then sampled the mRNA from 141 individual DGRP lines at high resolution - at about nine-minute intervals between each line. The idea behind this was to see how the gene transcripts changed over time in different lines, and get a handle on how the fruit fly's genetic background and circadian rhythm together affect the expression of different genes in distinct tissues.

"It allowed us to generate the first tissue-specific reference circadian gene expression time series in Drosophila; a comprehensive circadian gene-expression atlas," says Litovchenko. "But it also let us gain unprecedented insights into the extent and genome-wide nature of circadian gene expression variation using an innovative approach that allowed the reconstruction of dynamic cycling patterns from statically collected samples."

The study revealed three major points about the circadian rhythm.

The Clock reigns supreme

First, the scientists detected more than 1700 genes whose expression cycles under the control of the circadian clock, with only fourteen of those genes being the same across all tissues in the fruit fly.

"At least two of these fourteen were so far uncharacterized and significantly impact several locomotor activity rhythms parameters," says Litovchenko, referring to the fruit fly's behavioral patterns that depend on its circadian clock. "Since these genes have orthologs (similar genes) in mice, baboons, and humans, our findings strongly suggest that they are novel, core clock-regulators in mammals as well," she adds.

Morning person or night owl?

Second, that each individual may have its own circadian rhythm, which may explain the large range of human behaviors, such as morning people, nappers, evening people, night owls etc. The researchers used a state-of-the-art statistical approach to work out the natural circadian rhythm for every tissue in every DGRP fruit fly transcriptome.

What they found was that the physiological clock in about a third of Drosophila lines significantly deviates from the "natural" time by more than three hours. And most of the lines showed a circadian expression variation only in one or two tissues.

"Humans may also be impacted by such extensive variation," says Deplancke. "There seems to be an abundant, natural circadian asynchrony in molecular circadian rhythms between various tissues, which has to our knowledge not been observed before and which may have all kinds of physiological consequences in metabolic patterns, digestive fluctuations etc."

Light, dark, and a mutation

Finally, that a small genetic mutation can disrupt an individual's "photoentrainment", which refers to the aligning of the circadian rhythm to the pattern of light and dark in its environment.

Focusing on a Drosophila line with the highest unaligned circadian rhythm (more than 10 hours), the researchers found that it contains a novel, loss-of-function deletion in the Drosophila clock- and light-regulated gene "cry" (for "cryptochrome").

"This small deletion disrupts the light-driven FAD cofactor photoreduction," says Deplancke. "It confirms in vivo the importance of the evolutionary conserved photo-entrainment mechanism in the circadian pacemaker."

From fly to human

The study also reconfirmed that Drosophila is an excellent model for studying the circadian rhythm in humans, as it identified several new core clock genes that the two species share. "We have gained unique insights as to what extent the circadian clock is molecularly variable not only between individuals, but even between tissues of the same individual," says Deplancke.

"Obviously, we will never be able to achieve such insights in humans, as we cannot sample human tissues across 24 hours," he adds. "But what we learned is that this variation is very extensive. Given the increasing importance of chronopharmacology, it may be good to infer the innate circadian cycle of individuals before starting important drug treatments."

Credit: 
Ecole Polytechnique Fédérale de Lausanne

Trauma surgeons and emergency surgeons positively impact patient satisfaction

video: Critical Role of Trauma and Emergency Surgery Physicians in Patient Satisfaction: An Analysis of HCAHPS Data from 186,779 Patients and 168 Hospitals in a National Healthcare System.

Image: 
American College of Surgeons

CHICAGO (January 29, 2021): Trauma patients and patients who need emergency surgery have little to no opportunity to get acquainted with the surgeon and team that will perform their operation. However, a large study has found that effective and meaningful physician communication is a more important contributor to the overall satisfaction of trauma patients and those having emergency surgery than it is for patients admitted to the hospital for medical reasons or for elective procedures.

The study was selected for the 2020 Southern Surgical Association Program and published as an "article in press" on the website of the Journal of the American College of Surgeons in advance of print.

The researchers found an unexpectedly significant effect of physician communication among patients admitted through a hospital's trauma bay or emergency department. They analyzed patient survey data to determine how several factors, including interactions with nurses and doctors, contributed to satisfaction ratings in five different patient categories: trauma, direct-admit (elective) surgery, emergency department (ED)-admitted (emergency) surgery, ED-admitted medical, and direct-admit medical.

"Nurses uniformly come out as the most highly ranked, and that's because they provide wonderful bedside care and have so much contact with the patients," said lead study author Samir M. Fakhry, MD, FACS, vice president of the Center for Trauma and Acute Care Surgery Research for HCA Healthcare, a publicly traded company based in Nashville, Tenn., that operates 187 hospitals and other health care facilities. "But in the case of the trauma patients, and to a lesser degree the emergency surgical patients, physician communication ranked as the number two factor," he said.

Among elective surgery and medical admission patients, physician communication didn't register even as a third or fourth factor. "There's something about the way the trauma surgeons are delivering their care that is an important driver of the satisfaction scoring that is provided by our patients," Dr. Fakhry said.

The authors noted that no previous large study has investigated overall satisfaction among trauma and emergency surgery patients. Study investigators analyzed Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey data of 186,779 non-maternity patients discharged from 168 HCA Healthcare hospitals in 2018 and 2019. HCAHPS is a post-discharge survey that asks patients about their hospital experience. The Centers for Medicare and Medicaid Services uses HCAHPS data to generate hospital ratings reported on its Hospital Compare website. The survey captures patient impressions of a number of factors about the hospital experience, including communication with doctors and nurses.

The researchers found that physician communication had a greater impact on overall satisfaction after accounting for nursing factors among trauma and emergency surgery patients, representing a 12 percent boost in the former and an 8.6 percent boost in the latter. In categories in which physician communication received low ratings, it was unlikely that high scores in other factors could compensate to bring the overall satisfaction score above the 50th percentile.

"The things trauma surgeons and the people around them are doing seem to be very important to their patients," Dr. Fakhry said. "For many people in hospital leadership, the trauma service is an important mission of the hospital, but they wouldn't expect the trauma service to contribute very much to a positive patient experience because we're dealing with injured people. However, this study shows trauma care has a significant impact on hospital ratings."

The authors noted that future research should explore what specific aspects of the physician's behavior in trauma, emergency surgery, and ED admissions contribute to patient satisfaction.

"We like to say in the world of trauma that the 't' in trauma is for team, so it would be important to stress that the team approach we employ in trauma may be an important part of the findings of the study," Dr. Fakhry said. "That's something we're going to explore in future studies to try to determine what it is, specifically, that trauma surgeons are doing, how they relate to the nurses, and if the interaction between the doctor and the nurse are all something we can turn into an even more positive experience for the patient."

In an invited commentary, Thomas J. Esposito, MD, MPH, FACS, a professor at the University of Illinois College of Medicine, Peoria, noted the study focuses attention on the importance of communication, but also expressed reservations about the "reliability and veracity" of surveys, citing the inaccuracy of pre-election opinion polls in the last two presidential election cycles. "I would encourage these investigators to expand their research and further dive into the data as well as the survey process," Dr. Esposito wrote.

Credit: 
American College of Surgeons

How lipids distribute proteins within cells

An international team of scientists, coordinated by the Seville Institute of Biomedicine (IBiS) and the University of Seville has solved one of the hitherto unresolved enigmas of basic biology: how exactly do lipids distribute proteins within a cell? To do this, they used a new, completely innovative microscopy technology, which they applied to "mutant" cells they designed in their laboratory.

This discovery represents a major advance in understanding how proteins are distributed in cells to perform their vital functions, and could open the door to understanding the causes of diseases associated with failures in protein distribution at the cellular level: from cancer to neurodegenerative diseases, such as Alzheimer's.

The study was carried out by the Department of Cell Biology's "Membrane Trafficking" research group, part of the Faculty of Biology of the University of Seville and the IBiS, led by Professor Manuel Muñiz Guinea, in collaboration with the universities of Hiroshima (Japan), Geneva and Fribourg (Switzerland). The RIKEN Institute in Japan, where the "Super-resolution Living Cell Microscopy" Laboratory is located, also participated in this project. This is a unique facility in the world which conducted analyses using a high resolution fluorescence microscope that allows the study of very fast and dynamic processes in living cells on an incredibly small scale.

As Manuel Muñiz explains, "the cell is the basic unit of life and, at the same time, an extremely complex and sophisticated machine in which thousands of proteins, among other components, are strategically located in different compartments where they carry out cellular functions". The cell must ensure that its proteins are properly distributed to their place of function, because if this fails and they do not reach their destination, the proteins either stop working or get out of control, causing diseases ranging from genetic syndromes to cancer or neurological diseases. Therefore, it is important to investigate how proteins are distributed towards their functional destination.

Many years ago it was suggested that, in addition to cells' conventional protein transportation machinery (whose discovery received the Nobel Prize for Medicine in 2013), the lipids that make up the cell membranes may also play an additional role in the distribution of proteins within cells. This work by the Seville researchers solves this enigma of basic biology, demonstrating for the first time how lipids can distribute proteins at the cellular level.

Molecular exit doors

The proteins are manufactured in a compartment of the cell and then have to be distributed correctly by exiting through specific "doors". In this study, scientists from Seville discovered that membrane lipids are responsible for selecting and directing certain proteins to the correct exit doors.

To make this discovery, they designed a "mutant cell" that was programmed to manufacture a shortened version of cellular lipids called ceramides. The researchers suspected that the length of these lipids could be a determining factor in choosing the appropriate exit door.

"And that's exactly what we found," explains the IBiS researcher. "Thanks to the short ceramides we generated, we were able to demonstrate for the first time that lipids are only able to guide proteins during transport if they are the right length. Moreover, by using such a powerful 'super microscope' we were able to capture for the first time on an ultra small scale and in vivo how proteins exit through these molecular doors".

Yeast model

As a curiosity, this study was carried out using yeast cells (the same unicellular fungus used to make bread, beer and wine) as a model organism, "because, being eukaryotic cells just like ours, they perform the same basic cellular processes in a very similar way, so the observations can be extrapolated to human cells", explains the University of Seville professor.

However, because they are also simpler and can be genetically manipulated very effectively, "yeast cells are an excellent model to understand the fundamental workings of the human cell and what causes disease, as demonstrated by the fact that several Nobel Prize for Medicine have been awarded to researchers who used this microorganism in their studies, including Paul Nurse or Randy Schekman".

In conclusion, Manuel Muñiz explains that the article published in Science Advances "has also served to demonstrate that lipids and proteins influence each other to self-organise together within the cell", and points out that the mechanism they have discovered and used for this "could be used in other processes, such as the entry and exit of certain viruses from the cell, as well as in the formation of exosomes (extra-cellular lipid vesicles involved in communication between cells, particularly in cancer)".

Credit: 
University of Seville

Schoolchildren are learning about health through football (soccer)

image: Danish schoolchildren are learning about health through football - both girls and boys are enjoying it!

Image: 
Robert Wengler + 45 20430656 - robert@wengler.dk - www.wengler.dk

Knowledge about health is a cornerstone in a child's development of physical and psychosocial health.

Since 2016, around 25,000 pupils in years 4-6 in 86 of Denmark's municipalities have taken part in the project "11 for Health in Denmark", an 11-week exercise and health education programme offered to all schools in a collaboration between the University of Southern Denmark and the Danish Football Association.

More than 3,000 of these pupils completed questionnaires before and after the programme aimed at determining their knowledge about health and understanding their experience of the 11-week programme.

An increase of 10 percentage points in health knowledge

The main article from this study, which has now been published in leading sports science journal the British Journal of Sports Medicine, confirms that the programme is meeting its key objectives:

"The participating children increased their knowledge about health in the areas of diet, exercise, hygiene and wellbeing to a greater extent than the control group, which followed the originally planned lessons in the 11 weeks between the questionnaires. There was a difference between the groups of more than 7 percentage points for both boys and girls, and in a number of key health areas the difference was more than 10 percentage points," says postdoc Malte Nejst Larsen, the article's lead author.

"The idea that children learn best if they can connect the learning to relevant activities is not new, but it's rare for such large studies to be carried out in real-world schools - and with such unambiguous results," he says.

Physical activity during coronavirus

The "11 for Health" concept was developed long before the coronavirus epidemic, but it has proven effective in relation to all the current challenges around health, fitness, physical activity, wellbeing and knowledge about hygiene.

The latest results show very clearly that it is possible to combine health learning with exercise that is fun, motivational and inclusive for all children - including those who have very little experience of sport. A good example is that the children doubled their knowledge about hand hygiene through the programme.

This was explained by the project's lead researcher Professor Peter Krustrup of the Department of Sports Science and Clinical Biomechanics at the University of Southern Denmark, who stresses that there was record-high participation in autumn 2020.

The researchers are also, therefore, delighted that the Nordea Foundation (Nordea-fonden), which has been supporting the project since 2018, has extended its support through to summer 2021. The project group is currently seeking funding for an ambitious expansion of the concept and a research study of the concept's long-term effects.

Both boys and girls like the project

The article also provides data on the children's opinion of the programme. These show very encouragingly that the girls rate the programme just as highly as the boys (4 on a scale of 1-5), despite the fact that the girls generally have considerably less experience of football than the boys.

Bent Clausen, Vice President of the Danish Football Association with a focus on amateur football, is delighted about this:

"It is great that '11 for Health' is able to have a broad reach and spark an interest in football in all children, both boys and girls, beginners and experienced players. After all, that is what football is really good at - including everyone no matter what their background. And with the school programme a natural next step, and an important aid for the associations, is getting new players and including them in the valuable communities within the football clubs."

Credit: 
University of Southern Denmark Faculty of Health Sciences

Production of 'post-lithium-ion batteries' requires new skills

image: The coating of the electrodes is one of many process steps in complex battery cell production.

Image: 
WWU - MEET

Research on manufacturing battery cells is gaining momentum - and there is a strong need, considering the future demand for energy storage: For the year 2030, global production of rechargeable batteries will double from today's 750 gigawatt hours (GWh) per year to 1,500 GWh. A recently published review article in the magazine "Nature Energy" on cell production of various battery types suggests that the currently established lithium-ion batteries (LIB) dominate the market of rechargeable high-energy batteries in the coming years. Alternative battery technologies, in particular solid batteries, but also lithium-sulphur or lithium-air batteries are being researched intensively, but production on an industrial large scale is not yet taking place. Based on currently numerous emerging production capacities for LIBs, a switch to so-called post-lithium-ion batteries (PLIBs) with new process technologies, manufacturing environments and skills would require billion-dollar investments.

"Lithium-ion technology is expected to still dominate the market for high-energy rechargeable batteries over the next 10 years. It combines advantageous properties such as energy, power density, safety, durability and low costs in one. In addition, the production facilities currently being set worldwide are already creating facts that are likely to make it more difficult for the possible follow-up technologies to catch up," explains Dr Richard Schmuch, Deputy Head of Materials at MEET Battery Research Center at the University of Münster (Germany). He and Dr Fabian Duffner, Institute for Business Management in the Department of Chemistry and Pharmacy at the University of Münster and Porsche Consulting GmbH, led the analysis. Together with other battery and production researchers, they figured that production processes of LIBs cannot be transferred 1:1 to the vast majority of follow-up technologies. Dr Richard Schmuch states: "Here, numerous challenges and high investments await cell production."

Intensive Research and Development Activities Required

Only the production of sodium-ion batteries is comparable to lithium-ion batteries in many process steps. However, since this type of battery provides lower energy compared to LIB, it does not currently represent a perspective for the mass market that LIB has. The production processes of other post-lithium-ion batteries, such as solid-state, lithium-sulfur and lithium-air batteries, differ significantly from the production of lithium-ion batteries: Steps such as electrode manufacture, cell construction or cyclization require different techniques, manufacturing environments or machines.

Dr Fabian Duffner explains: "We currently know neither all the high-volume machines required nor the associated process parameters for cell production of post-lithium-ion batteries. Their industrialisation requires intensive research and development activities that focus on building up new manufacturing competences and developing new machines." In addition, post-LIBs would have to compete comprehensively in terms of all key performance parameters such as energy, performance, safety, durability and cost to become an alternative to the mass market.

Credit: 
University of Münster

A small protein in bacteria overlooked up to now

image: Photosynthesis is found at the beginning of nearly all food chains. Cyanobacteria use light as an energy source, too, and can carry out photosynthesis, similar to plants.

Image: 
Grafik: Wolfgang Hess

The biological process of photosynthesis is found at the beginning of nearly all food chains. It produces oxygen to breathe and provides the energetic foundation for using biotechnological processes to synthesize biofuels and chemical feedstock. Therefore, researchers are particularly interested in rapidly growing cyanobacteria. These organisms use light as an energy source and can carry out photosynthesis, similar to plants. However, the required photosynthetic protein complexes bind many nutrients. Vanessa Krauspe and Prof. Dr. Wolfgang Hess from the working group for Genetics & Experimental Bioinformatics of the Faculty of Biology of the University of Freiburg and their collaborators have discovered the small, previously unknown protein NblD, which is involved in the recycling of these nutrients. The researchers are presenting their new findings in the specialist journal PNAS.

In addition to the pigment chlorophyll, cyanobacteria use for photosynthesis frequently also phycobilisomes, complexes consisting of proteins and another class of tetrapyrrole pigments, which are considered as the most effective light-harvesting structures found in nature. However, using phycobilisomes is costly for the cell as they bind a huge amount of nutrients in their macromolecular structures - nitrogen in particular. In order to recycle these nutrients under scarcity conditions, for example under conditions of insufficient nitrogen supplies, the cyanobacteria have sophisticated genetic programs which, among scientists, are actually considered to be well-examined.

In a new approach, aiming at taking a closer look at especially small genes and proteins, the team at the University of Freiburg has been able to characterize NblD. It is a previously unknown small protein with high-affinity, meaning it rapidly forms bonds. NblD binds specifically to what is known as the phycocyanin beta-subunit of the phycobilosome. Through this process cyanobacterial cells receive special mechanisms to handle potentially dangerous intermediate products that occur during the recycling of the phycobilisomes. Hess says, "The results illustrate the fact that especially small genes and proteins have been neglected hitherto and deserve a closer look."

Credit: 
University of Freiburg

New research about emerging 'COVID-19 personality types'

image: New research just published identifies and explores the impacts of salient viral or COVID-19 behavioural identities that are emerging.

Image: 
Tony Picher

New research by Mimi E. Lam (University of Bergen) just published in Humanities and Social Sciences Communications identifies and explores the impacts of salient viral or COVID-19 behavioural identities that are emerging.

"These emergent COVID-19 behavioural identities are being hijacked by existing social and political identities to politicize the pandemic and heighten racism, discrimination, and conflict," says Lam. She continues: "the COVID-19 pandemic reminds us that we are not immune to each other. To unite in our fight against the pandemic, it is important to recognize the basic dignity of all and value the human diversity currently dividing us."

"Only then, can we foster societal resilience and an ethical COVID-19 agenda. This would pave the way for other global commons challenges whose impacts are less immediate, but no less dire for humanity.

Lam argues that liberal democracies need an ethical policy agenda with three priorities: 1. to recognize the diversity of individuals; 2. to deliberate and negotiate value trade-offs; and 3. to promote public buy-in, trust, and compliance.

Some emergent "COVID-19 personality types":

Deniers: who downplay the viral threat, promoting business as usual

Spreaders: who want it to spread, herd immunity to develop, and normality to return

Harmers: who try to harm others by, for example, spitting or coughing at them

Realists: who recognise the reality of the potential harm and adjust their behaviours

Worriers: who stay informed and safe to manage their uncertainty and fear

Contemplators: who isolate and re?ect on life and the world

Hoarders: who panic-buy and hoard products to quell their insecurity

Invincibles: often youth, who believe themselves to be immune

Rebels: who de?antly ?out social rules restricting their individual freedoms

Blamers: who vent their fears and frustrations onto others

Exploiters: who exploit the situation for power, pro?t or brutality

Innovators: who design or repurpose resources to fight the pandemic

Supporters: who show their solidarity in support of others

Altruists: who help the vulnerable, elderly, and isolated

Warriors: who, like the front-line health-care workers, combat its grim reality

Veterans: who experienced SARS or MERS and willingly comply with restrictions

Credit: 
The University of Bergen

How vitamins, steroids and potential antivirals might affect SARS-CoV-2

Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they - and other antiviral drugs - might work. The research indicates that these dietary supplements and compounds could bind to the viral spike protein and so might reduce SARS-CoV-2 infectivity. In contrast, cholesterol may increase infectivity, which could explain why having high cholesterol is considered a risk factor for serious disease.

Recently, Bristol researchers showed that linoleic acid binds to a specific site in the viral spike protein, and that by doing so, it locks the spike into a closed, less infective form. Now, a research team has used computational methods to search for other compounds that might have the same effect, as potential treatments. They hope to prevent human cells becoming infected by preventing the viral spike protein from opening enough to interact with a human protein (ACE2). New anti-viral drugs can take years to design, develop and test, so the researchers looked through a library of approved drugs and vitamins to identify those which might bind to this recently discovered 'druggable pocket' inside the SARS-CoV-2 spike protein.

The team first studied the effects of linoleic acid on the spike, using computational simulations to show that it stabilizes the closed form. Further simulations showed that dexamethasone - which is an effective treatment for COVID-19 - might also bind to this site and help reduce viral infectivity in addition to its effects on the human immune system.

The team then conducted simulations to see which other compounds bind to the fatty acid site. This identified some drugs that have been found by experiments to be active against the virus, suggesting that this may be one mechanism by which they prevent viral replication such as, by locking the spike structure in the same way as linoleic acid.

The findings suggested several drug candidates among available pharmaceuticals and dietary components, including some that have been found to slow SARS-CoV-2 reproduction in the laboratory. These have the potential to bind to the SARS-CoV-2 spike protein and may help to prevent cell entry.

The simulations also predicted that the fat-soluble vitamins D, K and A bind to the spike in the same way making the spike less able to infect cells.

Dr Deborah Shoemark, Senior Research Associate (Biomolecular Modelling) in the School of Biochemistry, who modelled the spike, explained: "Our findings help explain how some vitamins may play a more direct role in combatting COVID than their conventional support of the human immune system.

"Obesity is a major risk factor for severe COVID. Vitamin D is fat soluble and tends to accumulate in fatty tissue. This can lower the amount of vitamin D available to obese individuals. Countries in which some of these vitamin deficiencies are more common have also suffered badly during the course of the pandemic. Our research suggests that some essential vitamins and fatty acids including linoleic acid may contribute to impeding the spike/ACE2 interaction. Deficiency in any one of them may make it easier for the virus to infect."

Pre-existing high cholesterol levels have been associated with increased risk for severe COVID-19. Reports that the SARS-CoV-2 spike protein binds cholesterol led the team to investigate whether it could bind at the fatty acid binding site. Their simulations indicate that it could bind, but that it may have a destabilising effect on the spike's locked conformation, and favour the open, more infective conformation.

Dr Shoemark continued: "We know that the use of cholesterol lowering statins reduces the risk of developing severe COVID and shortens recovery time in less severe cases. Whether cholesterol de-stabilises the "benign", closed conformation or not, our results suggest that by directly interacting with the spike, the virus could sequester cholesterol to achieve the local concentrations required to facilitate cell entry and this may also account for the observed loss of circulating cholesterol post infection."

Professor Adrian Mulholland, of Bristol's School of Chemistry, added: "Our simulations show how some molecules binding at the linoleic acid site affect the spike's dynamics and lock it closed. They also show that drugs and vitamins active against the virus may work in the same way. Targeting this site may be a route to new anti-viral drugs. A next step would be to look at effects of dietary supplements and test viral replication in cells."

Alison Derbenwick Miller, Vice President, Oracle for Research, said: "It's incredibly exciting that researchers are gaining new insights into how SARS-CoV-2 interacts with human cells, which ultimately will lead to new ways to fight COVID-19. We are delighted that Oracle's high-performance cloud infrastructure is helping to advance this kind of world-changing research. Growing a globally-connected community of cloud-powered researchers is exactly what Oracle for Research is designed to do."

The team included experts from Bristol UNCOVER Group, including Bristol's Schools of Chemistry, Biochemistry, Cellular and Molecular Medicine, and Max Planck Bristol Centre for Minimal Biology, and Bristol Synthetic Biology Centre, using Bristol's high performance computers and the UK supercomputer, ARCHER, as well as Oracle cloud computing. The study was supported by grants from the EPSRC and the BBSRC.

Credit: 
University of Bristol

Football and inclusion: It all comes down to the right motivational climate

image: Anne-Marie Elbe, Professor of Sports Psychology at Leipzig University.

Image: 
Photo: Swen Reichhold, Leipzig University

This is the conclusion of a recent study by an international team of researchers, including Anne-Marie Elbe, Professor of Sports Psychology at Leipzig University. The finding is of social importance because experiences in adolescence in particular have a formative influence on attitudes and behaviour in later life.

In sport, football is considered a model of inclusion. "Remarkably, to the best of our knowledge, theory and research on feelings of inclusion in (youth) team sports is lacking," the authors write in their study. They add that filling this gap is important, because team sports are not necessarily inclusive by nature.

For their study, the Danish-Dutch-German team of researchers interviewed 245 boys aged 10 to 16 about their experiences. "We focused [on them] because particularly in these age groups, positive intercultural contact experiences tend to lead to more positive intergroup attitudes in adulthood," said the authors. The subjects belong to two Dutch football clubs that train very diverse teams. The majority of the study participants - 61.6 per cent - were classified as having "minority" social status. This means that the player himself or at least one of his parents was born outside the Netherlands.

For the research team, inclusion consists of two components, explains Anne-Marie Elbe from Leipzig University: "How strongly do I feel I belong to a team? And how strongly do I feel that I can be myself - so act authentically with regard to things like my other cultural background?" This understanding of inclusion is based on existing research by other scholars.

"Our assumption in the study was that there would be a relationship between a person's feeling of inclusion and what kind of motivational climate exists in the team, so the climate created by the coach," said Elbe. A distinction is made between a performance-oriented motivational climate on the one hand, where the aim is to be better than other players in your own team, and a task-oriented motivational climate on the other. With task-based standards, the focus is on the individual player and improving his own skills. Motivating each player to learn is important: does he succeed in doing a task well, or at least not doing it worse than before?

Professor Anne-Marie Elbe and her team of researchers have now shown that the young players' sense of inclusion correlated positively with a task-oriented training climate, while it correlated negatively with a climate based on competition. When both types of training were used side by side, non-migrant players still managed to cope well - without this impacting too heavily on their sense of belonging. Among the "minority" players, however, it was observed that their sense of inclusion was only stable where there was a stronger focus on task-based standards, and the competitive approach within their own team was either not emphasised or emphasised only to a limited extent.

"So you can't say that being a member of a football team in itself has positive effects. In order to achieve positive effects through football training, the coach needs to behave in a certain way and create a specific climate during the training session. There is a lot of potential in this, and it is of enormous significance to society," said Anne-Marie Elbe. "Our study helps extend the quantitative research on inclusion and sport."

Credit: 
Universität Leipzig

Researchers illustrate the need for anti-racism in kidney care, research

(Boston)--There is a growing awareness of systematic inequality and structural racism in American society. Science and medicine are no exception, as evidenced by historical instances of discrimination and overt racism.

In a perspective piece in the Journal of the American Society of Nephrology, researchers from Boston University School of Medicine (BUSM), take an honest look at how the current practice of nephrology (kidney medicine) may have elements rooted in racist ideologies.

For twenty years, kidney function has been estimated based on lab tests and equations that consider black vs. non-black race. Many institutions are now reconsidering whether this practice is defensible, and several have stopped reporting kidney function based on racial identity. The researchers contemplate what other aspects of clinical practice and research may have subtle racist undertones.

Despite the fact that race is now understood as a social rather than biological construct, many examples in nephrology implicitly assume a biological basis for race. Examples include the use of race in estimating the risk for kidney stones in black vs. white individuals, for assessing the suitability of kidneys from black vs. white individuals for transplantation, and in studies of kidney function and physiology. "The practice and teaching of nephrology in graduate and medical school today continues to perpetuate an ideology that is non-scientific, misleading to students and trainees and ultimately, corrosive to society," explains corresponding author Sushrut S. Waikar, MD, the Norman Levinsky professor of medicine at BUSM.

According to Waikar, reporting kidney function separately for "black" and "white" patients is setting the stage for people to accept a biological basis for race. "Kidney function tests are among the most commonly reported tests by laboratories around the world. Tens of thousands of lab reports every day make a distinction between "black" and "white" kidney function. This may influence the way we think about race, leading to subtle and pervasive racism in everyday clinical medicine," he adds.

Waikar and Insa Schmidt, MD, MPH, nephrologists at Boston Medical Center, stress that physicians and scientists have a moral obligation to take a critical look at historical practices that may be rooted in racist ideology, and re-think the appropriate use of race in medicine. "We believe we have an obligation as doctors and researchers to be advocates for social justice and anti-racism. We also have to be honest and call out our own practices when they fall short of this ideal."

Credit: 
Boston University School of Medicine

Scientists identify locations of early prion protein deposition in retina

image: (left panel) Early in prion infection, a prion protein aggregate (magenta) blocks the entrance to a cilium (green) in a retinal photoreceptor. (lower right) In prion-infected retina, prion protein (magenta) accumulates under the horseshoe-shaped ribbon synapses (green) found in photoreceptor terminals.

Image: 
NIAID

WHAT:

The earliest eye damage from prion disease takes place in the cone photoreceptor cells, specifically in the cilia and the ribbon synapses, according to a new study of prion protein accumulation in the eye by National Institutes of Health scientists. Prion diseases originate when normally harmless prion protein molecules become abnormal and gather in clusters and filaments in the human body and brain.

Understanding how prion diseases develop, particularly in the eye because of its diagnostic accessibility to clinicians, can help scientists identify ways to slow the spread of prion diseases. The scientists say their findings, published in the journal Acta Neuropathologica Communications, may help inform research on human retinitis pigmentosa, an inherited disease with similar photoreceptor degeneration leading to blindness.

Prion diseases are slow, degenerative and usually fatal diseases of the central nervous system that occur in people and some other mammals. Prion diseases primarily involve the brain, but also can affect the eyes and other organs. Within the eye, the main cells infected by prions are the light-detecting photoreceptors known as cones and rods, both located in the retina.

In their study, the scientists, from NIH's National Institute of Allergy and Infectious Diseases at Rocky Mountain Laboratories in Hamilton, Montana, used laboratory mice infected with scrapie, a prion disease common to sheep and goats. Scrapie is closely related to human prion diseases, such as variant, familial and sporadic Creutzfeldt-Jakob disease (CJD). The most common form, sporadic CJD, affects an estimated one in one million people annually worldwide. Other prion diseases include chronic wasting disease in deer, elk and moose, and bovine spongiform encephalopathy in cattle.

Using confocal microscopy that can identify prion protein and various retinal proteins at the same time, the scientists found the earliest deposits of aggregated prion protein in cone photoreceptors next to the cilia, tube-like structures required for transporting molecules between cellular compartments. Their work suggests that by interfering with transport through cilia, these aggregates may provide an important early mechanism by which prion infection selectively destroys photoreceptors. At a later study timepoint, they observed similar findings in rods.

Prion protein also was deposited in cones and rods adjacent to ribbon synapses just before the destruction of these structures and death of photoreceptors. Ribbon synapses are specialized neuron connections found in ocular and auditory neural pathways, and their health is critical to the function of retinal photoreceptors in the eye, as well as hair cells in the ear.

The researchers say such detailed identification of disease-associated prion protein, and the correlation with retinal damage, has not been seen previously and is likely to occur in all prion-susceptible species, including people.

Next the researchers are hoping to study whether similar findings occur in retinas of people with other degenerative diseases characterized by misfolded host proteins, such as Alzheimer's and Parkinson's diseases.

Credit: 
NIH/National Institute of Allergy and Infectious Diseases

New technique identifies important mutations behind Lynch Syndrome

Colorectal cancer is the third most common form of cancer. While 90% of cases are in people older than 50, there is an as-yet unexplained rising incidence in younger people.

Family history ranks high among risk factors for developing colorectal cancer, and people with such a history are often advised to get more frequent screening tests or start screening sooner than the recommended age of 45 years old. Those with a family history of cancer often seek out genetic tests to look for mutations linked to cancer risk. However, those tests don't always provide helpful information.

In a new paper in the American Journal of Human Genetics, Jacob Kitzman, Ph.D., of the Department of Human Genetics at Michigan Medicine, and a team of collaborators describe a method for screening so-called genetic variants of uncertain significance in the hopes of identifying those mutations that could cause disease.

To do this, they used a genetic condition called Lynch syndrome, also known as hereditary non-polyposis colorectal cancer. Like BRCA1, a gene known to cause certain breast cancers, there are a handful of genes behind Lynch syndrome that have been well described. However, "there's a whole universe of possible genetic variants that can occur in genes associated with Lynch syndrome that we basically know nothing about," says Kitzman.

Because most mutations are rare in the human population, it can be difficult to tell if any particular one is problematic. And studying one variant in a lab at a time takes a lot of time--often too much to be useful for making clinical decisions.

Using a technique called deep mutational scanning, the research team set out to measure the impact of mutations in the gene MSH2, which when mutated, is one major cause of Lynch syndrome.

"The key advance is rather than doing one mutation at a time, we did it in a pooled format which allowed us to test about 18,000 mutations in a single batch," says Kitzman.

Using CRISPR-Cas technology, they deleted the normal copy of MSH2 from human cells, and replaced it with library of every possible mutation in the MSH2 gene. This created a mix of cells where each cell carried a unique MSH2 mutation. This population of cells was treated with a drug known as 6-thioguanine, a chemotherapy that killed only the cells that had a functional variant of MSH2.

The counterintuitive idea, notes Kitzman, is that the surviving cells are the ones without functioning MSH2--which are the ones with mutations that are most likely to be disease-causing.

"We were basically trying to sit down and make the mutations we could so they could serve as a reference for ones that are newly seen or are amongst the thousands of variants of unknown significance identified in people from clinical testing," says Kitzman. "Until now, geneticists could not be sure whether these are benign or pathogenic."

The hope is that, with other patient-specific information, some of these variants may be able to be reclassified, and those people notified that they should undergo more intense screening.

Says Kitzman, "One of the next areas that will need some focus in the field of human genetics is to create these sorts of maps for many different genes where there is a clinical connection, so we can be more predictive when variants are found in an individual."

Credit: 
Michigan Medicine - University of Michigan